● Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

Condition: Alzheimer's Disease · Sponsor: Hoffmann-La Roche

PhasePhase 1

Planned participants50

Who can joinAll sexes, 50 Years to 75 Years

Healthy volunteersNo

About this study

This study aims to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, and pharmacodynamics following administration of RO7812653 in participants with eAD.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: BP45770 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (12)

Toronto Western Hospital	Toronto, Ontario, Canada	Recruiting
Montreal Neurological Institute Clinical Research Unit	Montreal, Quebec, Canada	Recruiting
Brain Research Center Amsterdam	Amsterdam, North Holland, Netherlands	Recruiting
Hospital General de Catalunya	Sant Cugat del Vallès, Barcelona, Spain	Recruiting
Hospital de la Santa Creu i Sant Pau	Barcelona, Spain	Recruiting
Hospital Universitario Reina Sofia	Córdoba, Spain	Recruiting
Sahlgrenska Universitetssjukhuset	Mlndal, Sweden	Recruiting
Karolinska Universitetssjukhuset	Solna, Sweden	Recruiting
Institute of Psychiatry, Psychology and Neuroscience;Department of Old Age Psychiatry	London, Greater London, United Kingdom	Recruiting
Southampton General Hospital	Southampton, Hampshire, United Kingdom	Recruiting
Queen Elizabeth Hospital	Glasgow, Strathclyde, United Kingdom	Recruiting
National Hospital For Neurology and Neurosurgery	London, United Kingdom	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07234942